Page last updated: 2024-09-04

fr 66973 and Pleural Effusion

fr 66973 has been researched along with Pleural Effusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Miyayasu, K; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S	1

Other Studies

1 other study(ies) available for fr 66973 and Pleural Effusion

Article	Year
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:1 Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured	1998

Article

Year

FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.

Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:1

Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured

1998